TREATMENT COMPLETION RATES OF OLANZAPINE AND RISPERIDONE IN LONG ACTING INJECTABLE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF SINGLE ARM OPEN-LABEL STUDIES

Authors:
  • HAHaya Ascher-Svanum
    Haya Ascher-Svanum
  • WMWilliam Montgmery
    William Montgmery
  • ABAllen Brnabic
    Allen Brnabic
  • ALAnthony Lawson
    Anthony Lawson
  • OTOladapo Tomori
    Oladapo Tomori
  • KCKristina Coleman
    Kristina Coleman
  • LLLibby Lynch
    Libby Lynch
  • PCPeining Chen
    Peining Chen
  • SAScott Andersen
    Scott Andersen
  • DMDavid McDonnell
    David McDonnell

Abstract
No abstract available